查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1701295

生物共軛市場規模、佔有率、趨勢分析報告（按產品/服務、方法、生物分子類型、應用、最終用途、地區、細分預測），2025 年至 2030 年

Bioconjugation Market Size, Share & Trends Analysis Report By Product & Services (Consumables, Instruments, Services), By Technique, By Biomolecule Type, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

生物共軛市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，全球生物共軛市場規模預計到2030年將達到96.7億美元，2025年至2030年期間的複合年成長率為9.54%。

生物偶聯產業的發展受到標靶治療需求的不斷成長以及腫瘤學和其他治療領域對抗體藥物複合體(ADC) 的日益廣泛應用的推動。精準醫療和位特異性生物結合技術的進步正在提高藥物療效並推動市場擴張。生物製藥研發投入的不斷增加，正在加速生技藥品、蛋白質結合和核酸治療方法的創新。

此外，診斷、生醫材料和藥物傳輸系統等領域的應用不斷擴大也推動了這一成長，尤其是隨著生物感測器和成像劑的採用日益增加。生物共軛合約研究（CRO）和契約製造（CMO）服務的激增進一步推動了市場的發展。此外，監管支援、策略性產業合作以及點擊化學和連接技術的技術進步是推動生物共軛產業向前發展的關鍵因素。

在 COVID-19 大流行期間，對生物結合技術的需求激增，尤其是在疫苗開發和快速診斷領域。生物共軛在增強抗原穩定性和免疫反應以及提高疫苗（例如基於 mRNA 的製劑）的功效方面發揮關鍵作用。此外，它們廣泛用於診斷檢測，可以透過生物感測器和免疫測量更快、更準確地檢測病毒。對大規模生產的迫切需求導致對 CRO 和 CMO 的外包增加，加速了研發和製造。這些因素凸顯了生物結合在應對疫情和疫苗創新中的重要角色。

此外，精準醫療和生技藥品的進步推動了對生物共軛技術的需求，從而實現了有針對性的藥物傳輸並提高了治療效果。抗體藥物複合體(ADC)、蛋白質療法和基因療法的興起推動了對精確位點特異性偶聯和改進的連接體化學的需求。生物共軛在個人化治療中也發揮關鍵作用，可確保更高的特異性並減少副作用。隨著生物製藥研究和開發的不斷擴大，生物共軛技術在藥物開發、診斷和生物材料中的應用不斷成長，塑造著現代醫學的未來。

然而，由於原料昂貴、設備專用、製造製程複雜，生物共軛藥物（如抗體-藥物偶聯物 (ADC) 和胜肽-藥物偶聯物 (PDC)）的開發成本較高。生產穩定有效的生物共軛物需要先進的連接技術、位點特異性的共軛方法和嚴格的品管，這進一步增加了成本。此外，高昂的研發成本和漫長的藥品核准時間為製藥和生技公司帶來了巨大的財務風險。監管障礙、大規模臨床試驗和可擴展性挑戰也使得生物結合藥物開發成為一個資本密集且耗時的過程，限制了小型公司和新興企業的進入。

生物共軛市場報告重點

  • 由於對生物結合過程所必需的試劑、連接劑和標記試劑套件的需求量很大，耗材部門在 2024 年佔據了市場最大收入佔有率，為 45.45%。研發活動的活性化和抗體藥物複合體（ADC）的日益普及進一步促進了該領域的成長。另一方面，預計服務業在預測期內將以最快的複合年成長率成長。
  • 基於技術，化學結合部分在 2024 年佔據了最大的市場收益佔有率。這是由於其高效率、擴充性以及在抗體藥物結合物 (ADC)、蛋白質標記和奈米顆粒功能化中的廣泛應用。其既定的通訊協定和與多種生物分子的兼容性進一步增強了它的優越性。另一方面，點擊化學領域預計在預測期內將以最快的複合年成長率成長。
  • 根據生物分子類型，抗體部分在 2024 年佔據了最大的市場收益佔有率，這得益於其在抗體藥物複合體(ADC)、標靶治療和免疫測量中的關鍵作用。其高特異性、穩定性以及在腫瘤、感染疾病和精準醫療領域的廣泛應用進一步增強了其市場優勢。另一方面，寡核苷酸部分預計在預測期內以最快的複合年成長率成長。
  • 根據應用，由於抗體藥物複合體(ADC)、胜肽藥物偶聯物 (PDC) 和標靶藥物輸送系統的採用日益增多，治療藥物領域預計將在 2024 年佔據最大的收益佔有率。精準醫療、生物製藥和癌症治療的需求不斷成長，推動市場的發展。另一方面，診斷領域預計在預測期內將以最快的複合年成長率成長。
  • 根據最終用途，製藥和生物技術公司部門在 2024 年佔據了最大的市場收益佔有率，這得益於研發投入的增加、對標靶治療藥物的需求以及抗體藥物複合體(ADC) 和生技藥品的開發。合作研究的增加、生物共軛服務的外包以及精準醫療的進步進一步推動了市場主導地位。另一方面，預計預測期內 CRO 和 CMO 部門的複合年成長率將最快。
  • 2024 年，北美佔據市場主導地位，收入佔有率為 43.75%，這得益於強勁的生物製藥研發投資、抗體藥物複合體(ADC) 的高度採用以及先進的醫療保健基礎設施。大型製藥和生物技術公司的存在、有利的監管支持以及對精準醫療的不斷成長的需求進一步推動了市場的成長。另一方面，預計亞太地區在預測期內的複合年成長率最快。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章生物共軛市場變數、趨勢與範圍

  • 市場展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 生物共軛市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • COVID-19影響分析

第4章生物共軛市場：產品和服務估計和趨勢分析

  • 產品/服務細分儀表板
  • 全球生物共軛市場產品與服務差異分析
  • 全球生物共軛市場規模和趨勢分析（按產品和服務，2018-2030 年）
  • 耗材
    • 試劑和套件
    • 標籤
    • 其他耗材
  • 裝置
    • 層析法系統
    • 光譜儀器
    • 質譜儀
    • 流式細胞儀
    • 電泳設備
    • 過濾系統
    • 攪拌機和攪拌機
    • 培養箱
    • 其他設備
  • 服務
    • 自訂合成和結合服務
    • 分析和表徵服務
    • 擴大生產和製造服務
    • 其他服務

第5章生物共軛市場：生物分子類型估計與趨勢分析

  • 生物分子類型細分儀表板
  • 全球生物共軛市場中生物分子類型的變異分析
  • 2018-2030年全球生物共軛市場規模及趨勢分析（依生物分子型態）
  • 抗體
  • 蛋白質
  • 胜肽
  • 寡核苷酸
  • 其他生物分子

第6章生物共軛市場：方法論評估與趨勢分析

  • 方法論細分儀表板
  • 全球生物共軛市場方法變異分析
  • 全球生物共軛市場規模及趨勢分析（依方法，2018-2030）
  • 化學鍵
  • 酶介導的結合
  • 點擊化學
  • 光反應交聯
  • 其他方法

第7章生物共軛市場：應用評估與趨勢分析

  • 應用程式細分儀表板
  • 全球生物共軛市場應用變遷分析
  • 全球生物共軛市場規模及應用趨勢分析（2018-2030）
  • 治療
    • 抗體藥物複合體
    • 蛋白質-藥物偶聯物
    • 胜肽-藥物偶聯物
    • 其他治療用途
  • 研究與開發
  • 診斷

第8章生物共軛市場：最終用途估計與趨勢分析

  • 最終用途細分儀表板
  • 全球生物共軛市場最終用途變化分析
  • 全球生物共軛市場規模與趨勢分析（依最終用途）（2018-2030）
  • 製藥和生物技術公司
  • CRO 和 CMO
  • 學術研究所
  • 醫院、臨床實驗室、診斷實驗室

第9章生物共軛市場：按產品/服務、生物分子類型、技術、應用和最終用途的區域估計和趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018年至2030年市場規模與預測趨勢分析：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章 競爭格局

  • 公司/競爭對手分類
  • 戰略地圖
  • 2024年企業市場分析
  • 公司簡介/列表
    • Danaher
    • Thermo Fisher Scientific Inc.
    • Lonza Group
    • Merck KGaA（MilliporeSigma）
    • Sartorius AG
    • Abbvie, Inc.
    • Bio-Rad Laboratories, Inc.
    • Agilent Technologies, Inc.
    • Catalent, Inc.
    • BD
Product Code: GVR-4-68040-537-0

Bioconjugation Market Growth & Trends:

The global bioconjugation market size is anticipated to reach USD 9.67 billion by 2030 and is projected to grow at a CAGR of 9.54% from 2025 to 2030, according to a new report by Grand View Research, Inc. The bioconjugation industry is driven by rising demand for targeted therapeutics and the growing adoption of antibody-drug conjugates (ADCs) in oncology and other treatments. Advancements in precision medicine and site-specific bioconjugation techniques are enhancing drug efficacy driving market expansion. Increasing biopharmaceutical R&D investments are accelerating innovation in biologics, protein conjugation, and nucleic acid-based therapies.

In addition, expanding applications in diagnostics, biomaterials, and drug delivery systems are also fueling growth, particularly with the rising adoption of biosensors and imaging agents. The surge in contract research (CROs) and contract manufacturing (CMOs) services for bioconjugation is further boosting market development. In addition, regulatory support, strategic industry collaborations, and technological advancements in click chemistry and linker technologies are key factors propelling the bioconjugation industry forward.

During the COVID-19 pandemic, the demand for bioconjugation technologies surged, particularly in vaccine development and rapid diagnostics. Bioconjugation played a crucial role in enhancing antigen stability and immune response, improving the efficacy of vaccines such as mRNA-based formulations. In addition, it was widely used in diagnostic assays, enabling faster and more accurate detection of the virus through biosensors and immunoassays. The urgent need for large-scale production led to increased outsourcing to CROs and CMOs, accelerating R&D and manufacturing. These factors underscored the critical role of bioconjugation in pandemic response and vaccine innovation.

Moreover, advancements in precision medicine and biologics are driving the demand for bioconjugation technologies, enabling targeted drug delivery and enhanced therapeutic efficacy. The rise of antibody-drug conjugates (ADCs), protein therapeutics, and gene therapies has increased the need for precise site-specific conjugation and improved linker chemistry. Bioconjugation also plays a key role in personalized treatments, ensuring higher specificity and reduced side effects. As biopharmaceutical R&D expands, the adoption of bioconjugation techniques in drug development, diagnostics, and biomaterials continues to grow, shaping the future of modern medicine.

However, the development of bioconjugated drugs, such as antibody-drug conjugates (ADCs) and peptide-drug conjugates (PDCs), involves high costs due to expensive raw materials, specialized equipment, and complex manufacturing processes. Producing stable and effective bioconjugates requires advanced linker technologies, site-specific conjugation methods, and stringent quality control, further driving up costs. In addition, high R&D expenses and long drug approval timelines pose significant financial risks for pharmaceutical and biotechnology companies. Regulatory hurdles, extensive clinical trials, and scalability challenges add to the burden, making bioconjugation drug development a capital-intensive and time-consuming process, limiting entry for smaller firms and startups.

Bioconjugation Market Report Highlights:

  • The consumables segment led the market with the largest revenue share of 45.45% in 2024, due to the high demand for reagents, linkers, and labeling kits essential for bioconjugation processes. Increasing R&D activities and the growing adoption of antibody-drug conjugates (ADCs) further fueled segment growth. On the other hand, the services segment is expected to grow at the fastest CAGR over the forecast period.
  • Based on technique, the chemical conjugation segment accounted for the largest market revenue share in 2024, due to its high efficiency, scalability, and widespread use in antibody-drug conjugates (ADCs), protein labeling, and nanoparticle functionalization. Its well-established protocols and compatibility with various biomolecules further drove its dominance. On the other hand, the click chemistry segment is expected to grow at the fastest CAGR over the forecast period.
  • Based on biomolecule type, the antibodies segment accounted for the largest market revenue share in 2024, due to their crucial role in antibody-drug conjugates (ADCs), targeted therapeutics, and immunoassays. Their high specificity, stability, and widespread application in oncology, infectious diseases, and precision medicine further drive market dominance. On the other hand, the oligonucleotides segment is expected to grow at the fastest CAGR over the forecast period.
  • Based on application, the therapeutics segment accounted for the largest revenue share in 2024, due to the rising adoption of antibody-drug conjugates (ADCs), peptide-drug conjugates (PDCs), and targeted drug delivery systems. Increasing demand for precision medicine, biologics, and cancer therapies further drives its market leadership. On the other hand, the diagnostics segment is expected to grow at the fastest CAGR over the forecast period.
  • Based on end use, the pharmaceutical & biotechnological companies segment accounted for the largest market revenue share in 2024, due to increasing R&D investments, demand for targeted therapeutics, and the development of antibody-drug conjugates (ADCs) and biologics. Growing collaborations, outsourcing of bioconjugation services, and advancements in precision medicine further fueled market dominance. On the other hand, the CROs & CMOs segment is expected to grow at the fastest CAGR over the forecast period.
  • The North America dominated the market with the largest revenue share of 43.75% in 2024, driven by strong biopharmaceutical R&D investments, high adoption of antibody-drug conjugates (ADCs), and advanced healthcare infrastructure. The presence of leading pharmaceutical & biotechnology companies, favorable regulatory support, and growing demand for precision medicine further fueled market growth. On the other hand, the Asia Pacific region is anticipated to grow at the fastest CAGR over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Services
    • 1.2.2. Biomolecule Type
    • 1.2.3. Technique
    • 1.2.4. Application
    • 1.2.5. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Bioconjugation Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising demand for targeted drug delivery
      • 3.2.1.2. Technological innovations in linker chemistry
      • 3.2.1.3. Growing applications in diagnostics
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High development costs
      • 3.2.2.2. Short shelf life of bioconjugated products
      • 3.2.2.3. Alternative drug delivery technologies
  • 3.3. Bioconjugation Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Bioconjugation Market: Product & Services Estimates & Trend Analysis

  • 4.1. Product & Services Segment Dashboard
  • 4.2. Global Bioconjugation Market Product & Services Movement Analysis
  • 4.3. Global Bioconjugation Market Size & Trend Analysis, by Product & Services, 2018 to 2030 (USD Million)
  • 4.4. Consumables
    • 4.4.1. Consumables market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Reagents & Kits
      • 4.4.2.1. Reagents & kits market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.2. Linker & Crosslinking Reagents & Kits
        • 4.4.2.2.1. Linker & crosslinking reagents & kits market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.3. Labeling Reagents & Kits
        • 4.4.2.3.1. Labeling reagents & kits market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.4. Modification Reagents & Kits
        • 4.4.2.4.1. Modification reagents & kits market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.5. Other Reagents & Kits
        • 4.4.2.5.1. Other reagents & kits market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Labels
      • 4.4.3.1. Labels market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.3.2. Fluorescent Tags
        • 4.4.3.2.1. Fluorescent tags market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.3.3. Enzymes
        • 4.4.3.3.1. Enzymes market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.3.4. Haptens
        • 4.4.3.4.1. Haptens market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.3.5. Polymers
        • 4.4.3.5.1. Polymers market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.3.6. Bead Coupling
        • 4.4.3.6.1. Bead coupling market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.3.7. Other Labels
        • 4.4.3.7.1. Other labels market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.4. Other Consumables
      • 4.4.4.1. Other consumables market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Instruments
    • 4.5.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.2. Chromatography Systems
      • 4.5.2.1. Chromatography systems market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.3. Spectroscopy Instruments
      • 4.5.3.1. Spectroscopy instruments market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.4. Mass Spectrometers
      • 4.5.4.1. Mass spectrometers market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.5. Flow Cytometers
      • 4.5.5.1. Flow cytometers market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.6. Electrophoresis Equipment
      • 4.5.6.1. Electrophoresis equipment market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.7. Filtration Systems
      • 4.5.7.1. Filtration systems market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.8. Mixers & Shakers
      • 4.5.8.1. Mixers & shakers market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.9. Incubators
      • 4.5.9.1. Incubators market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.10. Other Instruments
      • 4.5.10.1. Other instruments market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Services
    • 4.6.1. Services market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.6.2. Custom Synthesis & Conjugation Services
      • 4.6.2.1. Custom synthesis & conjugation services market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.6.3. Analytical & Characterization Services
      • 4.6.3.1. Analytical & characterization services market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.6.4. Scale-up & Manufacturing Services
      • 4.6.4.1. Scale-up & manufacturing services market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.6.5. Other Services
      • 4.6.5.1. Other services market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Bioconjugation Market: Biomolecule Type Estimates & Trend Analysis

  • 5.1. Biomolecule Type Segment Dashboard
  • 5.2. Global Bioconjugation Market Biomolecule Type Movement Analysis
  • 5.3. Global Bioconjugation Market Size & Trend Analysis, by Biomolecule Type, 2018 to 2030 (USD Million)
  • 5.4. Antibodies
    • 5.4.1. Antibodies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Proteins
    • 5.5.1. Proteins market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Peptides
    • 5.6.1. Peptides market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Oligonucleotides
    • 5.7.1. Oligonucleotides market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.8. Other Biomolecules
    • 5.8.1. Other biomolecules market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Bioconjugation Market: Technique Estimates & Trend Analysis

  • 6.1. Technique Segment Dashboard
  • 6.2. Global Bioconjugation Market Technique Movement Analysis
  • 6.3. Global Bioconjugation Market Size & Trend Analysis, by Technique, 2018 to 2030 (USD Million)
  • 6.4. Chemical Conjugation
    • 6.4.1. Chemical conjugation market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Enzyme-Mediated Conjugation
    • 6.5.1. Enzyme-mediated conjugation market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Click Chemistry
    • 6.6.1. Click chemistry market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7. Photoreactive Crosslinking
    • 6.7.1. Photoreactive crosslinking market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.8. Other Techniques
    • 6.8.1. Other techniques market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Bioconjugation Market: Application Estimates & Trend Analysis

  • 7.1. Application Segment Dashboard
  • 7.2. Global Bioconjugation Market Application Movement Analysis
  • 7.3. Global Bioconjugation Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 7.4. Therapeutics
    • 7.4.1. Therapeutics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.2. Antibody-drug Conjugates
      • 7.4.2.1. Antibody-drug conjugates market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.3. Protein-drug Conjugates
      • 7.4.3.1. Protein-drug conjugates market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.4. Peptide-drug Conjugates
      • 7.4.4.1. Peptide-drug conjugates market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.5. Other Therapeutic Applications
      • 7.4.5.1. Other therapeutic applications market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Research & Development
    • 7.5.1. Research & development market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Diagnostics
    • 7.6.1. Diagnostics market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Bioconjugation Market: End Use Estimates & Trend Analysis

  • 8.1. End Use Segment Dashboard
  • 8.2. Global Bioconjugation Market End Use Movement Analysis
  • 8.3. Global Bioconjugation Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 8.4. Pharmaceutical & Biotechnology Companies
    • 8.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.5. CROs & CMOs
    • 8.5.1. CROs & CMOs market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.6. Academic & Research Institutes
    • 8.6.1. Academic & research institutes market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.7. Hospitals, Clinical, & Diagnostic Laboratories
    • 8.7.1. Hospitals, clinical, & diagnostic laboratories market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 9. Bioconjugation Market: Regional Estimates & Trend Analysis by Product & Services, Biomolecule Type, Technique, Application, and End Use

  • 9.1. Regional Market Share Analysis, 2024 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 9.4. North America
    • 9.4.1. North America market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.4.2. U.S.
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Regulatory framework
      • 9.4.2.3. Competitive scenario
      • 9.4.2.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.4.3. Canada
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Regulatory framework
      • 9.4.3.3. Competitive scenario
      • 9.4.3.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.4.4. Mexico
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. Regulatory framework
      • 9.4.4.3. Competitive scenario
      • 9.4.4.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.5. Europe
    • 9.5.1. Europe market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.5.2. UK
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework
      • 9.5.2.3. Competitive scenario
      • 9.5.2.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.5.3. Germany
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Regulatory framework
      • 9.5.3.3. Competitive scenario
      • 9.5.3.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.5.4. France
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Regulatory framework
      • 9.5.4.3. Competitive scenario
      • 9.5.4.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.5.5. Italy
      • 9.5.5.1. Key country dynamics
      • 9.5.5.2. Regulatory framework
      • 9.5.5.3. Competitive scenario
      • 9.5.5.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.5.6. Spain
      • 9.5.6.1. Key country dynamics
      • 9.5.6.2. Regulatory framework
      • 9.5.6.3. Competitive scenario
      • 9.5.6.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.5.7. Norway
      • 9.5.7.1. Key country dynamics
      • 9.5.7.2. Regulatory framework
      • 9.5.7.3. Competitive scenario
      • 9.5.7.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.5.8. Sweden
      • 9.5.8.1. Key country dynamics
      • 9.5.8.2. Regulatory framework
      • 9.5.8.3. Competitive scenario
      • 9.5.8.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.5.9. Denmark
      • 9.5.9.1. Key country dynamics
      • 9.5.9.2. Regulatory framework
      • 9.5.9.3. Competitive scenario
      • 9.5.9.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.6. Asia Pacific
    • 9.6.1. Asia Pacific market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.6.2. Japan
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework
      • 9.6.2.3. Competitive scenario
      • 9.6.2.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.6.3. China
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Regulatory framework
      • 9.6.3.3. Competitive scenario
      • 9.6.3.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.6.4. India
      • 9.6.4.1. Key country dynamics
      • 9.6.4.2. Regulatory framework
      • 9.6.4.3. Competitive scenario
      • 9.6.4.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.6.5. Australia
      • 9.6.5.1. Key country dynamics
      • 9.6.5.2. Regulatory framework
      • 9.6.5.3. Competitive scenario
      • 9.6.5.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.6.6. South Korea
      • 9.6.6.1. Key country dynamics
      • 9.6.6.2. Regulatory framework
      • 9.6.6.3. Competitive scenario
      • 9.6.6.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.6.7. Thailand
      • 9.6.7.1. Key country dynamics
      • 9.6.7.2. Regulatory framework
      • 9.6.7.3. Competitive scenario
      • 9.6.7.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.7. Latin America
    • 9.7.1. Latin America market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.7.2. Brazil
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Regulatory framework
      • 9.7.2.3. Competitive scenario
      • 9.7.2.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.7.3. Argentina
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Regulatory framework
      • 9.7.3.3. Competitive scenario
      • 9.7.3.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.8. MEA
    • 9.8.1. MEA market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.8.2. South Africa
      • 9.8.2.1. Key country dynamics
      • 9.8.2.2. Regulatory framework
      • 9.8.2.3. Competitive scenario
      • 9.8.2.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.8.3. Saudi Arabia
      • 9.8.3.1. Key country dynamics
      • 9.8.3.2. Regulatory framework
      • 9.8.3.3. Competitive scenario
      • 9.8.3.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.8.4. UAE
      • 9.8.4.1. Key country dynamics
      • 9.8.4.2. Regulatory framework
      • 9.8.4.3. Competitive scenario
      • 9.8.4.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.8.5. Kuwait
      • 9.8.5.1. Key country dynamics
      • 9.8.5.2. Regulatory framework
      • 9.8.5.3. Competitive scenario
      • 9.8.5.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company/Competition Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Market Position Analysis, 2024
  • 10.4. Company Profiles/Listing
    • 10.4.1. Danaher
      • 10.4.1.1. Company overview
      • 10.4.1.2. Financial performance
      • 10.4.1.3. Product benchmarking
      • 10.4.1.4. Strategic initiatives
    • 10.4.2. Thermo Fisher Scientific Inc.
      • 10.4.2.1. Company overview
      • 10.4.2.2. Financial performance
      • 10.4.2.3. Product benchmarking
      • 10.4.2.4. Strategic initiatives
    • 10.4.3. Lonza Group
      • 10.4.3.1. Company overview
      • 10.4.3.2. Financial performance
      • 10.4.3.3. Product benchmarking
      • 10.4.3.4. Strategic initiatives
    • 10.4.4. Merck KGaA (MilliporeSigma)
      • 10.4.4.1. Company overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Product benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. Sartorius AG
      • 10.4.5.1. Company overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Product benchmarking
      • 10.4.5.4. Strategic initiatives
    • 10.4.6. Abbvie, Inc.
      • 10.4.6.1. Company overview
      • 10.4.6.2. Financial performance
      • 10.4.6.3. Product benchmarking
      • 10.4.6.4. Strategic initiatives
    • 10.4.7. Bio-Rad Laboratories, Inc.
      • 10.4.7.1. Company overview
      • 10.4.7.2. Financial performance
      • 10.4.7.3. Product benchmarking
      • 10.4.7.4. Strategic initiatives
    • 10.4.8. Agilent Technologies, Inc.
      • 10.4.8.1. Company overview
      • 10.4.8.2. Financial performance
      • 10.4.8.3. Product benchmarking
      • 10.4.8.4. Strategic initiatives
    • 10.4.9. Catalent, Inc.
      • 10.4.9.1. Company overview
      • 10.4.9.2. Financial performance
      • 10.4.9.3. Product benchmarking
      • 10.4.9.4. Strategic initiatives
    • 10.4.10. BD
      • 10.4.10.1. Company overview
      • 10.4.10.2. Financial performance
      • 10.4.10.3. Product benchmarking
      • 10.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global bioconjugation market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 4 Global bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 5 Global bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 6 Global bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 7 Global bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 8 North America bioconjugation market, by country, 2018 - 2030 (USD Million)
  • Table 9 North America bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 10 North America bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 11 North America bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 12 North America bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 13 North America bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 14 U.S. bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 15 U.S. bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 16 U.S. bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 17 U.S. bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 18 U.S. bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Canada bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 20 Canada bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 21 Canada bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 22 Canada bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 23 Canada bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Mexico bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 25 Mexico bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 26 Mexico bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 27 Mexico bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 28 Mexico bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Europe bioconjugation market, by country, 2018 - 2030 (USD Million)
  • Table 30 Europe bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 31 Europe bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 32 Europe bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 33 Europe bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 34 Europe bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Germany bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 36 Germany bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 37 Germany bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 38 Germany bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 39 Germany bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 40 UK bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 41 UK bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 42 UK bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 43 UK bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 44 UK bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 45 France bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 46 France bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 47 France bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 48 France bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 49 France bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Italy bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 51 Italy bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 52 Italy bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 53 Italy bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 54 Italy bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 55 Spain bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 56 Spain bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 57 Spain bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 58 Spain bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 59 Spain bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Denmark bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 61 Denmark bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 62 Denmark bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 63 Denmark bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 64 Denmark bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Sweden bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 66 Sweden bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 67 Sweden bioconjugation market, by technique, 2018 - 2030 (USD Million
  • Table 68 Sweden bioconjugation market, by application, 2018 - 2030 (USD Million
  • Table 69 Sweden bioconjugation market, by end use, 2018 - 2030 (USD Million
  • Table 70 Norway bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 71 Norway bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 72 Norway bioconjugation market, by technique, 2018 - 2030 (USD Million
  • Table 73 Norway bioconjugation market, by application, 2018 - 2030 (USD Million
  • Table 74 Norway bioconjugation market, by end use, 2018 - 2030 (USD Million
  • Table 75 Asia Pacific bioconjugation market, by country, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific bioconjugation market, by technique, 2018 - 2030 (USD Million
  • Table 78 Asia Pacific bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific bioconjugation market, by application, 2018 - 2030 (USD Million
  • Table 80 Asia Pacific bioconjugation market, by end use, 2018 - 2030 (USD Million
  • Table 81 China bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 82 China bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 83 China bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 84 China bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 85 China bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Japan bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 87 Japan bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 88 Japan bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 89 Japan bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 90 Japan bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 91 India bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 92 India bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 93 India bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 94 India bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 95 India bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 96 South Korea bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 97 South Korea bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 98 South Korea bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 99 South Korea bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 100 South Korea bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 101 Australia bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 102 Australia bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 103 Australia bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 104 Australia bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 105 Australia bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 106 Thailand bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 107 Thailand bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 108 Thailand bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 109 Thailand bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 110 Thailand bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 111 Latin America bioconjugation market, by country, 2018 - 2030 (USD Million)
  • Table 112 Latin America bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 113 Latin America bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 114 Latin America bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 115 Latin America bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 116 Latin America bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 117 Brazil bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 118 Brazil bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 119 Brazil bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 120 Brazil bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 121 Brazil bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 122 Argentina bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 123 Argentina bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 124 Argentina bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 125 Argentina bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 126 Argentina bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 127 MEA bioconjugation market, by country, 2018 - 2030 (USD Million)
  • Table 128 MEA bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 129 MEA bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 130 MEA bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 131 MEA bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 132 MEA bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 133 South Africa bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 134 South Africa bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 135 South Africa bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 136 South Africa bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 137 South Africa bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 138 Saudi Arabia bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 143 UAE bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 144 UAE bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 145 UAE bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 146 UAE bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 147 UAE bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 148 Kuwait bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 149 Kuwait bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 150 Kuwait bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 151 Kuwait bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 152 Kuwait bioconjugation market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Bioconjugation market: Market outlook
  • Fig. 5 Bioconjugation market: Segment outlook
  • Fig. 6 Bioconjugation market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Bioconjugation market driver impact
  • Fig. 9 Bioconjugation market restraint impact
  • Fig. 10 Bioconjugation market: Product & services outlook and key takeaways
  • Fig. 11 Bioconjugation market: Product & services movement analysis
  • Fig. 12 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 13 Kits & reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Linker & crosslinking reagents & kits market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Labeling reagents & kits market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Modification reagents & kits market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Other reagents & kits market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Labels market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Fluorescent tags market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Enzymes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Haptens market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Polymers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Bead coupling market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Other labels market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Other consumables market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Chromatography systems market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Spectroscopy instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Mass spectrometers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Flow cytometers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Electrophoresis equipment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Filtration systems market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Mixers & shakers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Incubators market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Other instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Custom synthesis & conjugation services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Analytical & characterization services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Scale-up & manufacturing services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Other services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Bioconjugation market: Biomolecule type outlook and key takeaways
  • Fig. 42 Bioconjugation market: Biomolecule type movement analysis
  • Fig. 43 Antibodies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Proteins market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Peptides market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Oligonucleotides market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Other biomolecules market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Bioconjugation market: Technique outlook and key takeaways
  • Fig. 49 Bioconjugation market: Technique movement analysis
  • Fig. 50 Chemical conjugation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Enzyme-mediated conjugation market estimates and forecast, 2018 - 2030 (USD Million
  • Fig. 52 Click chemistry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Photoreactive crosslinking market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Other techniques market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Bioconjugation market: Application outlook and key takeaways
  • Fig. 56 Bioconjugation market: Application movement analysis
  • Fig. 57 Therapeutics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Antibody-drug conjugates market estimates and forecast, 2018 - 2030 (USD Million
  • Fig. 59 Protein-drug conjugates market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Peptide-drug conjugates market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Other therapeutic applications market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Research & Development market estimates and forecast, 2018 - 2030 (USD Million
  • Fig. 63 Diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Bioconjugation market: End use outlook and key takeaways
  • Fig. 65 Bioconjugation market: End use movement analysis
  • Fig. 66 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 CROs & CMOs market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 68 Academic & research institutes market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 69 Hospitals, clinical, & diagnostic laboratories market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 70 Global bioconjugation market: Regional outlook and key takeaways
  • Fig. 71 Global bioconjugation market: Regional movement analysis
  • Fig. 72 North America bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 US bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Canada bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Mexico bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Europe bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 UK bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Germany bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 France bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Italy bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Spain bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Denmark bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Sweden bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Norway bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Asia Pacific bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 China bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Japan bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 India bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Thailand bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 South Korea bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Australia bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Latin America bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Brazil bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Argentina bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Middle East and Africa bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 South Africa bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Saudi Arabia bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 UAE bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Kuwait bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)